LncRNA DLEU7-AS1通过调控膜突蛋白MSN的表达促进胃癌细胞增殖与迁移的作用机制

肖岚姝; 潘柳荻; 刘毅; 王洁; 陈惠

doi:10.19401/j.cnki.1007-3639.2023.04.003

您当前的位置：

首页 >

文章列表页 >

LncRNA DLEU7-AS1通过调控膜突蛋白MSN的表达促进胃癌细胞增殖与迁移的作用机制

论著 | 更新时间：2025-12-31

- LncRNA DLEU7-AS1通过调控膜突蛋白MSN的表达促进胃癌细胞增殖与迁移的作用机制
- LncRNA DLEU7-AS1 contributes to proliferation and migration of gastric cancer by regulating MSN transcription
- 中国癌症杂志 2023年33卷第4期页码：327-341
- 作者机构：
  
  1. 上海交通大学医学院附属新华医院检验科，上海 200092
  2. 上海市瑞金康复医院检验科，上海 200023
- 作者简介：
  
  [ "肖岚姝（ORCID：0000-0003-2555-8230），硕士。" ]
  陈惠（ORCID：0000-0001-9115-6526），博士，硕士研究生导师，副主任技师。
- 基金信息：
  
  国家自然科学基金面上项目(81874152);国家自然科学基金青年项目(81903038)
- DOI：10.19401/j.cnki.1007-3639.2023.04.003
  中图分类号： R735.2
- 收稿：2022-12-06，
  
  修回：2023-03-16，
  
  纸质出版：2023-04-30
- 稿件说明：
移动端阅览
肖岚姝, 潘柳荻, 刘毅, 等. LncRNA DLEU7-AS1通过调控膜突蛋白MSN的表达促进胃癌细胞增殖与迁移的作用机制[J]. 中国癌症杂志, 2023,33(4):327-341.

Lanshu XIAO, Liudi PAN, Yi LIU, et al. LncRNA DLEU7-AS1 contributes to proliferation and migration of gastric cancer by regulating MSN transcription[J]. China Oncology, 2023, 33(4): 327-341.
肖岚姝, 潘柳荻, 刘毅, 等. LncRNA DLEU7-AS1通过调控膜突蛋白MSN的表达促进胃癌细胞增殖与迁移的作用机制[J]. 中国癌症杂志, 2023,33(4):327-341. DOI： 10.19401/j.cnki.1007-3639.2023.04.003.

Lanshu XIAO, Liudi PAN, Yi LIU, et al. LncRNA DLEU7-AS1 contributes to proliferation and migration of gastric cancer by regulating MSN transcription[J]. China Oncology, 2023, 33(4): 327-341. DOI： 10.19401/j.cnki.1007-3639.2023.04.003.

摘要

背景与目的：

越来越多的研究表明长链非编码RNA（long non-coding RNA

lncRNA）在肿瘤的发生、发展过程中发挥着重要作用，然而大多数lncRNA在胃癌中的作用和机制尚不明确。LncRNA DLEU7-AS1在胃癌中的作用和机制的研究鲜见报道。本文旨在研究DLEU7-AS1对胃癌恶性表型的影响并初步探讨其分子机制。

方法：

采用癌症基因组图谱（the Cancer Genome Atlas，TCGA）数据库分析DLEU7-AS1在胃癌组织中的表达及其对胃癌患者生存期的影响。采用实时荧光定量聚合酶链反应（real-time fluorescence quantitative polymerase chain reaction，RTFQ-PCR）验证DLEU7-AS1在胃癌组织及胃癌细胞系中的表达情况。采用5-氮杂-2’-脱氧胞苷（5-aza-2’-deoxycytidine，DAC）和曲古抑菌素A（trichostatin A，TSA）处理胃癌细胞株，分析表观遗传学调控对DLEU7-AS1表达的影响。采用小干扰RNA（small interfering RNA，siRNA）下调HGC-27、AGS细胞株中DLEU7-AS1的表达，采用重组质粒上调MGC-803和MKN-45中DLEU7-AS1的表达，采用RTFQ-PCR验证效果；采细胞计数试剂盒（cell counting kit-8，CCK-8）细胞增殖毒性实验、transwell小室迁移实验、平板克隆形成实验以及流式细胞术研究DLEU7-AS1对胃癌细胞增殖、迁移及凋亡和细胞周期的影响；采用RNA测序技术（RNA-sequencing，RNA-seq）分析沉默DLEU7-AS1后的下游信号转导通路的变化，并采用RTFQ-PCR和蛋白质印迹法（Western blot）进行验证；采用RNA免疫共沉淀实验（co-immunoprecipitation，RIP）探讨DLEU7-AS1对下游信号分子的调控机制。

结果：

TCGA数据库分析及RTFQ-PCR检测均证明 DLEU7-AS1在胃癌中表达升高。DLEU7-AS1的表达与胃癌患者生存期呈负相关。DAC和TSA处理胃癌细胞株后，DLEU7-AS1表达上调，说明其表达受表观遗传学调控。沉默DLEU7-AS1抑制胃癌细胞增殖、迁移，促进细胞凋亡；过表达DLEU7-AS1促进胃癌细胞增殖、迁移，抑制细胞凋亡。RNA-seq结果表明，DLEU7-AS1表达下调后会导致膜突蛋白（moesin，MSN）表达量的显著降低，RTFQ-PCR及Western blot的结果验证了这一结论。Rescue实验结果进一步证实，过表达MSN可部分回复干扰DLEU7-AS1对胃癌细胞增殖和迁移的抑制作用，提示MSN可能作为DLEU7-AS1下游效应分子。DLEU7-AS1主要定位在细胞核中，DLEU7-AS1与P300结合以及MSN启动子附近的H3K27的高度富集。

结论：

LncRNA DLEU7-AS1在胃癌中高表达并且其表达与胃癌患者生存期呈负相关，DLEU7-AS1可能通过招募P300调控MSN的转录进而促进胃癌的增殖和迁移等恶性表型。

Abstract

Background and purpose:

An increasing number of studies have demonstrated that lncRNA plays a critical role in the occurrence and development of tumors. However

the function of lncRNA in human gastric cancer remains largely unknown. So far

the role and mechanism of lncRNA DLEU7-AS1 in gastric cancer have not been reported. This study aimed to investigate the effect of DLEU7-AS1on the tumorigenesis and progression of gastric cancer and its mechanism.

Methods:

The publ

ic database the Cancer Genome Atlas (TCGA) was used to analyze the expression of DLEU7-AS1 in gastric cancer tissues and the correlation between its expression and the survival of gastric cancer patients. Then real-time fluorescence quantitative polymerase chain reaction (RTFQ-PCR) was performed to verify the expression of DLEU7-AS1 in gastric cancer tissues and gastric cancer cell lines. Gastric cancer cell lines were treated with 5-aza-2’-deoxycytidine (DAC) and trichostatin A (TSA) to explore whether epigenetic regulation participated in DLEU7-AS1 transcription. SiRNA was used to down-regulate the expression of DLEU7-AS1 in HGC-27 and AGS cells

and recombinant plasmid was used to up-regulate the expression of DLEU7-AS1 in MGC-803 and MKN-45. The effect was verified by RTFQ-PCR. Cell biological experiments

such as cell counting kit-8 (CCK-8) cell proliferation toxicity test

transwell chamber assay

plate colony formation assay and flow cytometry were used to investigate the effect of DLEU7-AS1 on the proliferation

migration

apoptosis and cell cycle progression of gastric cancer cells. RNA sequencing (RNA-seq) was used to analyze downstream signal pathways after silencing DLEU7-AS1 and tested by RTFQ-PCR and Western blot. And RNA Co-immunoprecipitation (RIP) was used to explore the regulatory mechanism of DLEU7-AS1 on downstream signal molecules.

Results:

The results of public database analysis and RTFQ-PCR demonstrated that DLEU7-AS1 was up-regulated in gastric cancer tissues compared with normal tissues. DLEU7-AS1 expression was negatively correlated with the survival of gastric cancer patients. DLEU7-AS1 was up-regulated in gastric cancer cell lines treated with DAC and TSA

indicating that its expression was epigenetically regulated. DLEU7-AS1 downregulation inhibited gastric cancer cells proliferation and migration and promoted cell apoptosis

while overexpression of DLEU7-AS1 promoted cell proliferation and metastasis and inhibited cell apoptosis. The results of RNA-seq showed that the do

wnregulation of DLEU7-AS1 expression led to a significant decrease in moesin (MSN) expression

which was confirmed by RTFQ-PCR and Western blot. Rescue experiment results further verified that MSN overexpression could partially restore the inhibition effect of knockdown of DLEU7-AS1 on the proliferation and migration of gastric cancer cells. Considering that DLEU7-AS1 mainly located in the nucleus

DLEU7-AS1 binding to P300 and H3K27 highly enriched near the MSN promoter

it was proposed that DLEU7-AS1 might regulate the expression of MSN by recruiting P300

thus contributing to the proliferation and migration of gastric cancer cells.

Conclusion:

LncRNA DLEU7-AS1 is abnormally up-regulated in gastric cancer and negatively correlated with survival of gastric cancer patients. DLEU7-AS1 may promote the proliferation and migration of gastric cancer by recruiting P300 to regulate the transcription of MSN

which provides a new idea for the diagnosis and treatment of gastric cancer..

关键词

Keywords

references

SUNG H , FERLAY J , SIEGEL R L , et al . Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J ] . CA Cancer J Clin , 2021 , 71 ( 3 ): 209 - 249 . DOI: 10.3322/caac.v71.3 http://doi.org/10.3322/caac.v71.3 https://onlinelibrary.wiley.com/toc/15424863/71/3 https://onlinelibrary.wiley.com/toc/15424863/71/3

SMYTH E C , NILSSON M , GRABSCH H I , et al . Gastric cancer [J ] . The Lancet , 2020 , 396 ( 10251 ): 635 - 648 . DOI: 10.1016/S0140-6736(20)31288-5 http://doi.org/10.1016/S0140-6736(20)31288-5 https://linkinghub.elsevier.com/retrieve/pii/S0140673620312885 https://linkinghub.elsevier.com/retrieve/pii/S0140673620312885

QIU H B , CAO S M , XU R H . Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020 [J ] . Cancer Commun , 2021 , 41 ( 10 ): 1037 - 1048 . DOI: 10.1002/cac2.v41.10 http://doi.org/10.1002/cac2.v41.10 https://onlinelibrary.wiley.com/toc/25233548/41/10 https://onlinelibrary.wiley.com/toc/25233548/41/10

CHEN W Q , ZHENG R S , BAADE P D , et al . Cancer statistics in China, 2015 [J ] . CA A Cancer J Clin , 2016 , 66 ( 2 ): 115 - 132 . DOI: 10.3322/caac.21338 http://doi.org/10.3322/caac.21338 http://doi.wiley.com/10.3322/caac.21338 http://doi.wiley.com/10.3322/caac.21338

XIA C F , DONG X S , LI H , et al . Cancer statistics in China and United States, 2022: profiles, trends, and determinants [J ] . Chin Med J (Engl) , 2022 , 135 ( 5 ): 584 - 590 .

HERMAN A B , TSITSIPATIS D , GOROSPE M . Integrated lncRNA function upon genomic and epigenomic regulation [J ] . Mol Cell , 2022 , 82 ( 12 ): 2252 - 2266 . DOI: 10.1016/j.molcel.2022.05.027 http://doi.org/10.1016/j.molcel.2022.05.027

HUARTE M . The emerging role of lncRNAs in cancer [J ] . Nat Med , 2015 , 21 ( 11 ): 1253 - 1261 . DOI: 10.1038/nm.3981 http://doi.org/10.1038/nm.3981

TAN Y T , LIN J F , LI T , et al . LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer [J ] . Cancer Commun (Lond) , 2021 , 41 ( 2 ): 109 - 120 .

JUSIC A , THOMAS P B , WETTINGER S B , et al . Noncoding RNAs in age-related cardiovascular diseases [J ] . Ageing Res Rev , 2022 , 77 : 101610 . DOI: 10.1016/j.arr.2022.101610 http://doi.org/10.1016/j.arr.2022.101610 https://linkinghub.elsevier.com/retrieve/pii/S1568163722000526 https://linkinghub.elsevier.com/retrieve/pii/S1568163722000526

SUN P , HAMBLIN M H , YIN K J . Non-coding RNAs in the regulation of blood-brain barrier functions in central nervous system disorders [J ] . Fluids Barriers CNS , 2022 , 19 ( 1 ): 27 . DOI: 10.1186/s12987-022-00317-z http://doi.org/10.1186/s12987-022-00317-z

LIU X B , HAN C , SUN C Z . Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway [J ] . Eur Rev Med Pharmacol Sci , 2018 , 22 ( 1 ): 110 - 117 .

WANG X J , CHEN L , XU R , et al . DLEU7-AS1 promotes renal cell cancer by silencing the miR-26a-5p/coronin-3 axis [J ] . Clin Kidney J , 2022 , 15 ( 8 ): 1542 - 1552 . DOI: 10.1093/ckj/sfac061 http://doi.org/10.1093/ckj/sfac061 https://academic.oup.com/ckj/article/15/8/1542/6539352 https://academic.oup.com/ckj/article/15/8/1542/6539352

WANG C Z , MA B B , XU Z J , et al . Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia [J ] . Biosci Rep , 2022 , 42 ( 5 ): BSR20212078.

ENCODE PROJECT CONSORTIUM . An integrated encyclopedia of DNA elements in the human genome [J ] . Nature , 2012 , 489 ( 7414 ): 57 - 74 . DOI: 10.1038/nature11247 http://doi.org/10.1038/nature11247

HUANG W X , LI H , YU Q S , et al . LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond [J ] . J Exp Clin Cancer Res , 2022 , 41 ( 1 ): 100 . DOI: 10.1186/s13046-022-02319-z http://doi.org/10.1186/s13046-022-02319-z

LI K , WANG Z Q . lncRNA NEAT1: key player in neurodegenerative diseases [J ] . Ageing Res Rev , 2023 , 86 : 101878 . DOI: 10.1016/j.arr.2023.101878 http://doi.org/10.1016/j.arr.2023.101878 https://linkinghub.elsevier.com/retrieve/pii/S1568163723000375 https://linkinghub.elsevier.com/retrieve/pii/S1568163723000375

NOJIMA T , PROUDFOOT N J . Mechanisms of lncRNA biogenesis as revealed by nascent transcriptomics [J ] . Nat Rev Mol Cell Biol , 2022 , 23 ( 6 ): 389 - 406 .

LIU J , LIU Z X , WU Q N , et al . Long noncoding RNA AGPG regulates PFKFB3-mediated tumor glycolytic reprogramming [J ] . Nat Commun , 2020 , 11 ( 1 ): 1507 . DOI: 10.1038/s41467-020-15112-3 http://doi.org/10.1038/s41467-020-15112-3

JI X S , LIU Z H , GAO J J , et al . N6-Methyladenosine-modified lncRNA LINREP promotes glioblastoma progression by recruiting the PTBP1/HuR complex [J ] . Cell Death Differ , 2023 , 30 ( 1 ): 54 - 68 . DOI: 10.1038/s41418-022-01045-5 http://doi.org/10.1038/s41418-022-01045-5

MCCABE E M , RASMUSSEN T P . lncRNA involvement in cancer stem cell function and epithelial-mesenchymal transitions [J ] . Semin Cancer Biol , 2021 , 75 : 38 - 48 . DOI: 10.1016/j.semcancer.2020.12.012 http://doi.org/10.1016/j.semcancer.2020.12.012

LIU H , LI D X , SUN L N , et al . Interaction of lncRNA MIR100HG with hnRNPA2B1 facilitates m6A-dependent stabilization of TCF7L2 mRNA and colorectal cancer progression [J ] . Mol Cancer , 2022 , 21 ( 1 ): 74 . DOI: 10.1186/s12943-022-01555-3 http://doi.org/10.1186/s12943-022-01555-3

LI Z , LANG Z Q , WANG T , et al . LncRNA SNHG22 promotes gastric cancer progression by regulating the miR-101-3p/e2f2 axis [J ] . Cell Cycle , 2023 , 22 ( 3 ): 347 - 360 . DOI: 10.1080/15384101.2022.2119515 http://doi.org/10.1080/15384101.2022.2119515 https://www.tandfonline.com/doi/full/10.1080/15384101.2022.2119515 https://www.tandfonline.com/doi/full/10.1080/15384101.2022.2119515

LIN Z H , SONG J L , GAO Y K , et al . Hypoxia-induced HIF-1α/lncRNA-PMAN inhibits ferroptosis by promoting the cytoplasmic translocation of ELAVL1 in peritoneal dissemination from gastric cancer [J ] . Redox Biol , 2022 , 52 : 102312 . DOI: 10.1016/j.redox.2022.102312 http://doi.org/10.1016/j.redox.2022.102312 https://linkinghub.elsevier.com/retrieve/pii/S2213231722000842 https://linkinghub.elsevier.com/retrieve/pii/S2213231722000842

MANGEAT P , ROY C , MARTIN M . ERM proteins in cell adhesion and membrane dynamics [J ] . Trends Cell Biol , 1999 , 9 ( 5 ): 187 - 192 .

DEGRYSE B , BRITTO M , SHAN C X , et al . Moesin and merlin regulate urokinase receptor-dependent endothelial cell migration, adhesion and angiogenesis [J ] . Int J Biochem Cell Biol , 2017 , 88 : 14 - 22 . DOI: S1357-2725(17)30090-0 http://doi.org/S1357-2725(17)30090-0

LI Y Q , ZHENG Z , LIU Q X , et al . Moesin as a prognostic indicator of lung adenocarcinoma improves prognosis by enhancing immune lymphocyte infiltration [J ] . World J Surg Oncol , 2021 , 19 ( 1 ): 109 . DOI: 10.1186/s12957-021-02229-y http://doi.org/10.1186/s12957-021-02229-y

SUN X , LI K X , HASE M , et al . Suppression of breast cancer-associated bone loss with osteoblast proteomes via Hsp90ab1/moesin-mediated inhibition of TGFβ/FN1/CD44 signaling [J ] . Theranostics , 2022 , 12 ( 2 ): 929 - 943 . DOI: 10.7150/thno.66148 http://doi.org/10.7150/thno.66148

YU L F , ZHAO L , WU H Z , et al . Moesin is an independent prognostic marker for ER-positive breast cancer [J ] . Oncol Lett , 2019 , 17 ( 2 ): 1921 - 1933 . DOI: 10.3892/ol.2018.9799 http://doi.org/10.3892/ol.2018.9799

KAMIOKA H , TOMONO T , FUJITA A , et al . Moesin-mediated P-glycoprotein activation during snail-induced epithelial-mesenchymal transition in lung cancer cells [J ] . J Pharm Sci , 2020 , 109 ( 7 ): 2302 - 2308 . DOI: 10.1016/j.xphs.2020.03.008 http://doi.org/10.1016/j.xphs.2020.03.008 https://linkinghub.elsevier.com/retrieve/pii/S0022354920301337 https://linkinghub.elsevier.com/retrieve/pii/S0022354920301337

浏览量

2724

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

DIAPH3对胃癌细胞增殖、迁移和侵袭的影响及分子机制

TMCO1对宫颈癌细胞增殖和迁移能力的影响

PRMT7通过调控Notch信号转导通路抑制膀胱癌细胞增殖和迁移

m6Am修饰酶PCIF1调控靶基因ACOT8参与胃癌进展的机制研究

tRF-Pro-CGG对小鼠胰腺癌细胞生物学行为的影响及其分子机制